These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 708161)

  • 21. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P-450 and drug oxidation.
    Davies DS
    Biochem J; 1969 Dec; 115(5):23P-24P. PubMed ID: 4391248
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on the combination of drugs. IV. Effect of 4-hydroxyantipyrine and N-acetyl-p-aminophenol on the metabolism of phenylbutazone, oxyphenbutazone and ketophenylbutazone].
    Niwa H; Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):838-42. PubMed ID: 5750523
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on the combination of drugs. VI. Effect of 4-hydroxyantipyrine etheral derivatives on metabolism of aminopyrine, phenacetin, acetanilide, and phenylbutazone].
    Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):847-51. PubMed ID: 5750525
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
    Shrewsbury RP
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent progress in pharmacogenetics.
    Vesell ES
    Adv Pharmacol (1962); 1969; 7():1-52. PubMed ID: 4190237
    [No Abstract]   [Full Text] [Related]  

  • 29. Impairment of phenytoin parahydroxylation as a cause of severe intoxication.
    de Wolff FA; Vermeij P; Ferrari MD; Buruma OJ; Breimer DD
    Ther Drug Monit; 1983 Jun; 5(2):213-5. PubMed ID: 6879646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependence of drug plasma level decline in dogs.
    Dayton PG; Cucinell SA; Weiss M; Perel JM
    J Pharmacol Exp Ther; 1967 Nov; 158(2):305-16. PubMed ID: 4169043
    [No Abstract]   [Full Text] [Related]  

  • 31. Lead and polychlorinated biphenyls: effects on heme and drug metabolism.
    Alvares AP; Kappas A
    Drug Metab Rev; 1979; 10(1):91-106. PubMed ID: 118861
    [No Abstract]   [Full Text] [Related]  

  • 32. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.
    Rowland M
    Eur J Pharmacol; 1972 Mar; 17(3):352-6. PubMed ID: 5022150
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional status of the liver during chronic renal failure: an experimental study in the rabbit.
    Tvedegaard E; Poulsen HE; Vilstrup H; Thomsen HK
    Liver; 1985 Aug; 5(4):183-8. PubMed ID: 3932805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of nifedipine, nitrendipine and verapamil at low concentration on antipyrine metabolism examined by extracorporeal rat liver perfusion.
    Szelag A; Magdalan J; Rutkowska M; Dziewiszek W; Trocha M; Rzepka M; Pieśniewska M; Fereniec L
    Pol J Pharmacol; 2003; 55(2):203-8. PubMed ID: 12926547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.
    Pollack GM; Browne JL; Marton J; Haberer LJ
    Drug Metab Dispos; 1991; 19(1):130-4. PubMed ID: 1673385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
    Kubow S; Wells PG
    Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug metabolism in a geriatric population.
    O'Malley K; Stevenson IH; Crooks J
    Clin Sci; 1971 Aug; 41(2):6P. PubMed ID: 5564320
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.